Suppr超能文献

肾血氧水平依赖磁共振成像测量肾组织氧合:一份声明文件和系统评价。

Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review.

机构信息

Service of Nephrology and Hypertension, Department of Medicine, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.

出版信息

Nephrol Dial Transplant. 2018 Sep 1;33(suppl_2):ii22-ii28. doi: 10.1093/ndt/gfy243.

Abstract

Tissue hypoxia plays a key role in the development and progression of many kidney diseases. Blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) is the most promising imaging technique to monitor renal tissue oxygenation in humans. BOLD-MRI measures renal tissue deoxyhaemoglobin levels voxel by voxel. Increases in its outcome measure R2* (transverse relaxation rate expressed as per second) correspond to higher deoxyhaemoglobin concentrations and suggest lower oxygenation, whereas decreases in R2* indicate higher oxygenation. BOLD-MRI has been validated against micropuncture techniques in animals. Its reproducibility has been demonstrated in humans, provided that physiological and technical conditions are standardized. BOLD-MRI has shown that patients suffering from chronic kidney disease (CKD) or kidneys with severe renal artery stenosis have lower tissue oxygenation than controls. Additionally, CKD patients with the lowest cortical oxygenation have the worst renal outcome. Finally, BOLD-MRI has been used to assess the influence of drugs on renal tissue oxygenation, and may offer the possibility to identify drugs with nephroprotective or nephrotoxic effects at an early stage. Unfortunately, different methods are used to prepare patients, acquire MRI data and analyse the BOLD images. International efforts such as the European Cooperation in Science and Technology (COST) action 'Magnetic Resonance Imaging Biomarkers for Chronic Kidney Disease' (PARENCHIMA) are aiming to harmonize this process, to facilitate the introduction of this technique in clinical practice in the near future. This article represents an extensive overview of the studies performed in this field, summarizes the strengths and weaknesses of the technique, provides recommendations about patient preparation, image acquisition and analysis, and suggests clinical applications and future developments.

摘要

组织缺氧在许多肾脏疾病的发生和发展中起着关键作用。血氧水平依赖磁共振成像(BOLD-MRI)是监测人类肾脏组织氧合的最有前途的成像技术。BOLD-MRI 逐像素测量肾脏组织去氧血红蛋白水平。其结果测量指标 R2*(以每秒为单位表示的横向弛豫率)的增加对应于更高的去氧血红蛋白浓度,表明更低的氧合,而 R2*的降低则表明更高的氧合。BOLD-MRI 已经在动物身上得到了微穿刺技术的验证。在人类中,只要生理和技术条件标准化,其重现性就已经得到了证明。BOLD-MRI 表明患有慢性肾脏病(CKD)或严重肾动脉狭窄的肾脏的组织氧合水平低于对照组。此外,皮质氧合最低的 CKD 患者的肾脏预后最差。最后,BOLD-MRI 已被用于评估药物对肾脏组织氧合的影响,并可能提供在早期识别具有肾保护或肾毒性作用的药物的可能性。不幸的是,不同的方法用于准备患者、获取 MRI 数据和分析 BOLD 图像。欧洲科学与技术合作组织(COST)的一项名为“磁共振成像慢性肾脏病生物标志物”(PARENCHIMA)的行动正在努力协调这一过程,以便在不久的将来将这项技术引入临床实践。本文代表了该领域所进行的研究的广泛概述,总结了该技术的优缺点,提供了有关患者准备、图像采集和分析的建议,并提出了临床应用和未来发展的建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d32/6106642/269786723d39/gfy243f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验